IFNG and cancer: Furthermore, cancer cell proliferation was also inhibited by the use of the mTORC inhibitor; in contrast, overexpression of S6K, the downstream substrate of mTORC (Figure 5B), further enhanced the proliferation of cancer cells that had been stimulated by IFN-γ (Figure 5C).